AI assistant
Sending…
Anterix Inc. — Director's Dealing 2024
Dec 12, 2024
33018_dirs_2024-12-11_6ba6b887-0701-427a-8cdb-8f8f9bc53f74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-12-09
Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-09 | Common Stock | M | 90000 | $25 | Acquired | 113973 | Direct |
| 2024-12-09 | Common Stock | F | 76391 | $34.05 | Disposed | 37582 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-09 | Stock Option (Right to Buy) | $25 | M | 90000 | Disposed | 2025-01-29 | Common Stock (90000) | Direct |
Footnotes
F1: This price reflects the closing price of the Issuer's Common Stock on the Nasdaq Capital Market on December 9, 2024.
F2: The option shares are fully vested and the option would have expired by its terms on January 29, 2025.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19